Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29135604 | 0.94 | NPSR1 (0.60) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL6863134 | 0.92 | NPSR1 (0.57) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL692776 | 0.90 | NPSR1 (0.63) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL7475995 | 0.89 | NPSR1 (0.53) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL691868 | 0.87 | NPSR1 (0.60) | NPSR1ALDH1A1 | |
| SCHEMBL13084353 | 0.87 | NPSR1 (0.60) | NPSR1ALDH1A1 | |
| SCHEMBL691923 | 0.85 | NPSR1 (0.61) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL6231540 | 0.84 | NPSR1 (0.50) | NPSR1ALDH1A1LMNAL3MBTL1MEN1 | |
| SCHEMBL29135724 | 0.82 | NPSR1 (0.55) | NPSR1ALDH1A1L3MBTL1 | |
| SCHEMBL25713906 | 0.82 | NPSR1 (0.55) | NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117229160-B | Triester cationic lipid compounds, compositions containing same and uses thereof | 北京悦康科创医药科技股份有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117229160-A | Triester cationic lipid compounds, compositions containing same and uses thereof | 北京悦康科创医药科技股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| EP-2421904-B1 | PROCATALYST COMPOSITION WITH ADAMANTANE AND METHOD | GRACE W R & CO (US) | 2015-06-24 | — | — | EP | disclosed |
| US-8288304-B2 | Procatalyst composition with adamantane and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288304-B2 | Procatalyst composition with adamantane and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288304-B2 | Procatalyst composition with adamantane and method | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-10-16 | — | — | US | disclosed |
| EP-2421904-A1 | PROCATALYST COMPOSITION WITH ADAMANTANE AND METHOD | Dow Global Technologies LLC (US) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010123775-A1 | PROCATALYST COMPOSITION WITH ADAMANTANE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010123775-A1 | PROCATALYST COMPOSITION WITH ADAMANTANE AND METHOD | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100273966-A1 | Procatalyst Composition with Adamantane and Method | W. R. GRACE & CO.-CONN. | 2010-10-28 | — | — | US | disclosed |
| US-20100273966-A1 | Procatalyst Composition with Adamantane and Method | W. R. GRACE & CO.-CONN. | 2010-10-28 | — | — | US | disclosed |
| US-20100273966-A1 | Procatalyst Composition with Adamantane and Method | W. R. GRACE & CO.-CONN. | 2010-10-28 | — | — | US | disclosed |